반응식
[CH2:1]([C:3]1(O)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2].[N+:14]([C:17]1[CH:18]=[CH:19][CH:20]=[C:21]2[C:25]=1[NH:24][CH:23]=[CH:22]2)([O-:16])=[O:15]>>[CH2:1]([C:3]1([C:22]2[C:21]3[C:25](=[C:17]([N+:14]([O-:16])=[O:15])[CH:18]=[CH:19][CH:20]=3)[NH:24][CH:23]=2)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2]참가 물질
3
실험 절차
Utilizing 1-ethyl-5-fluoro-indan-1-ol and 7-nitroindole, the title compound is prepared as in example 1. 0.37 g (42%). NMR (400 MHz, CDCl3): δ 0.85 (t, 3H), 2.18 (m, 2H), 2.35 (m, 1H), 2.53 (m, 1H), 3.00 (m, 2H), 6.83 (t, 1H), 6.92 (t, 1H), 7.01 (m, 2H), 7.08 (s, 1H), 7.44 (d, 1H), 8.09 (d, 1H), 9.76 (s, 1H, NH).
출처 및 근거
- ORD 기록
- ord-d3b53d47a7464cf58225fafbafc2677c
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07728150B2
연결된 노트
불러오는 중…